BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12054675)

  • 1. PPAR activators inhibit endothelial cell migration by targeting Akt.
    Goetze S; Eilers F; Bungenstock A; Kintscher U; Stawowy P; Blaschke F; Graf K; Law RE; Fleck E; Gräfe M
    Biochem Biophys Res Commun; 2002 May; 293(5):1431-7. PubMed ID: 12054675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands.
    Goetze S; Bungenstock A; Czupalla C; Eilers F; Stawowy P; Kintscher U; Spencer-Hänsch C; Graf K; Nürnberg B; Law RE; Fleck E; Gräfe M
    Hypertension; 2002 Nov; 40(5):748-54. PubMed ID: 12411472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
    Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.
    Yamakawa K; Hosoi M; Koyama H; Tanaka S; Fukumoto S; Morii H; Nishizawa Y
    Biochem Biophys Res Commun; 2000 May; 271(3):571-4. PubMed ID: 10814503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
    Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells.
    Gratton JP; Morales-Ruiz M; Kureishi Y; Fulton D; Walsh K; Sessa WC
    J Biol Chem; 2001 Aug; 276(32):30359-65. PubMed ID: 11387313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
    Takano H; Nagai T; Asakawa M; Toyozaki T; Oka T; Komuro I; Saito T; Masuda Y
    Circ Res; 2000 Sep; 87(7):596-602. PubMed ID: 11009565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells.
    Lin R; LeCouter J; Kowalski J; Ferrara N
    J Biol Chem; 2002 Mar; 277(10):8724-9. PubMed ID: 11751915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression.
    Blum S; Issbrüker K; Willuweit A; Hehlgans S; Lucerna M; Mechtcheriakova D; Walsh K; von der Ahe D; Hofer E; Clauss M
    J Biol Chem; 2001 Sep; 276(36):33428-34. PubMed ID: 11445586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of experimental retinal neovascularization to thiazolidinediones.
    Murata T; Hata Y; Ishibashi T; Kim S; Hsueh WA; Law RE; Hinton DR
    Arch Ophthalmol; 2001 May; 119(5):709-17. PubMed ID: 11346398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells.
    Takeda K; Ichiki T; Tokunou T; Iino N; Takeshita A
    J Biol Chem; 2001 Dec; 276(52):48950-5. PubMed ID: 11687581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
    Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
    Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.
    Huang WC; Chio CC; Chi KH; Wu HM; Lin WW
    Exp Cell Res; 2002 Jul; 277(2):192-200. PubMed ID: 12083801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
    Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages.
    Jozkowicz A; Dulak J; Piatkowska E; Placha W; Dembinska-Kiec A
    Acta Biochim Pol; 2000; 47(4):1147-57. PubMed ID: 11996104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling.
    Gupta K; Kshirsagar S; Li W; Gui L; Ramakrishnan S; Gupta P; Law PY; Hebbel RP
    Exp Cell Res; 1999 Mar; 247(2):495-504. PubMed ID: 10066377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
    Marx N; Kehrle B; Kohlhammer K; Grüb M; Koenig W; Hombach V; Libby P; Plutzky J
    Circ Res; 2002 Apr; 90(6):703-10. PubMed ID: 11934839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
    Qiao M; Shapiro P; Kumar R; Passaniti A
    J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
    Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
    Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.